Wed, April 5, 2023
Tue, April 4, 2023
Mon, April 3, 2023
Sat, April 1, 2023
Fri, March 31, 2023
Thu, March 30, 2023
Wed, March 29, 2023

Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-mar-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jonathan Wolleben of JMP Securities, Reiterated "Altimmune, Inc." (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023.

Jonathan has made no other calls on ALT in the last 4 months.



There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 1 agrees with Jonathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, March 22nd, 2023


These are the ratings of the 2 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, March 9th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023